The Latest Breaking News from FDA

On Wednesday, the Centers for Medicare Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ultrasound (uRDN) technologies for uncontrolled hypertension. This coverage would be granted under a Coverage with Evidence Development (CED) framework, requiring treatment within…

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) moved closer to potential FDA approval for its Cardamyst (etripamil) nasal spray, an investigational therapy for paroxysmal supraventricular tachycardia (PSVT), as the U.S. Food and Drug Administration (FDA) accepted the company’s response to prior issues.

Many of our favorite childhood snacks and candies exist as fond, sugary memories. We remember the commercials, the colorful packaging, and the joy they brought. However, some of these beloved treats were quietly removed from the market not because of low sales, but because they posed genuine health and safety…

Recently, I found myself pouring my heart out, not to a human, but to a chatbot named Wysa on my phone. It nodded – virtually – asked me how I was feeling and gently suggested trying breathing exercises.

Smoking is the primary driver of tobacco-related deaths and is highly restricted in most Swedish public places.

US blueberry recall upgraded to deadly risk due to listeria. UK consumers urged to check imports and watch for symptoms.

Mondelēz is recalling four RITZ cracker sandwich cartons after some individually wrapped peanut butter packs were mistakenly labeled as cheese

Would you be willing to take Ozempic, despite the potential side effects?

The Galaxy Watch 8 is a meaningful update for Samsung’s smartwatch lineup, adding a slimmer design, smarter health features, and built-in Gemini AI. Here are my hands-on impressions with both the Watch 8 and Watch 8 Classic